FDA approves Abilify for treating children with autism

11/23/2009 | Bloomberg Businessweek · Disability Scoop

The FDA approved the drug Abilify for treating aggression and irritability in children ages 6 to 17 who have autism. The approval was based on two studies that showed Abilify, commonly used to treat schizophrenia, depression and bipolar disorder, improved irritability in patients given the drug compared with those given a placebo. The drug's makers said the medication should be used in combination with psychological, social and educational therapies.

View Full Article in:

Bloomberg Businessweek · Disability Scoop

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Senior Turnaround Consultant (Job ID: 8274)
American Institutes of Research
Chicago, IL
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Regional Program Managers
ASCD
Multiple Locations, SL_Multiple Locations
Principal
DC Public Schools
Washington DC, DC
Superintendent of Schools
Berkeley County School District
Moncks Corner, SC